Denmark

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Institutional investors — the future of crypto is in their hands. Or is it not?

Source Node: https://coinrabbit.io/blog/institutional-investors-the-future-of-crypto-is-in-their-hands-or-is-it-not/
Time Stamp: December 30, 2020 6:02 AM - Modified On: May 21, 2021 - Published By:
Source Cluster:
Republished By Plato

Institutional investors are believed to drive the cryptocurrency market’s adoption and growth. Their involvement promises to make crypto widely recognized and accepted as a truly global currency. Bitcoin is supposed to gradually become an alternative to gold and skyrocket to unprecedented crypto prices.  But is this really how institutional investors work? In which direction are they actually driving the crypto market — and, after all, who are they? In this article, we will bring you the latest examples of huge whales’ interest in crypto, discover the reasons for that, and